Taner Akalin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taner Akalin has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Gulsen Kandiloglu
4 shared publications- Banu Yaman
Department of Pathology, Ege University Faculty of Medicine, Izmir, Turkey
3 shared publications - Banu Yaman
Department of Pathology, Ege University Faculty of Medicine, Izmir, Turkey
2 shared publications - Bengu Gerceker Turk
Special office, İzmir
2 shared publications - Ilgen Ertam
Department of Dermatology and Venereology Faculty of Medicine, Ege University Izmir Türkiye
2 shared publications - Ahmet Kayahan Tekneci
Ege University Faculty of Medicine, İzmir, Türkiye
1 shared publication
Latest Publications
- 28 August 2025
- Published by Springer Nature in International Ophthalmology
- Vol. 45 (1) , 1-7
Clinical, demographic, and outcome differences between isolated and non-isolated lacrimal gland involvement in idiopathic orbital inflammation
Purpose To evaluate the clinical data of idiopathic orbital inflammation with isolated and non-isolated lacrimal gland involvement. Methods The medical records of patients who were diagnosed with idiopathic orbital inflammation between January 2016 and June 2022 were evaluated. The patients were divided into 2 groups: isolated and non-isolated lacrimal gland involvement, and were compared in terms of clinical characteristics, response to treatment and recurrence rates. Results Thirty-three eyes of 32 patients (21 female, 11 male) were included in the study. The mean age of the patients was 47.4 ± 14.8 (range, 11–70). The mean follow-up period was 37.4 ± 21.5 (range, 6–76) months. Isolated lacrimal gland involvement was found in 18 eyes (54.5%), myositis and orbital adipose tissue involvement in addition to lacrimal gland involvement in 13 eyes (39.4%), and diffuse orbital inflammation in two eyes (6.1%). While a total of 24 patients (75.0%) were treated with systemic steroids alone, immunosuppressive drugs were used in addition to steroids in eight patients (25.0%). In patients with isolated lacrimal gland involvement, complete recovery with steroid treatment was significantly higher (p = 0.02), while the need for immunosuppressant medication (p = 0.02) and recurrence rates (p = 0.006) were found to be significantly lower. Conclusion To the best of our knowledge, this is the first study to describe and compare the clinical features and treatment outcomes of lacrimal gland biopsy-proven idiopathic orbital inflammation according to the extent of involvement. Knowing whether lacrimal gland involvement is isolated or not may help predict steroid resistance and recurrence risk in patient management.
- 28 August 2025
- Published by Springer Nature in International Ophthalmology
- Vol. 45 (1) , 1-7
Clinical, demographic, and outcome differences between isolated and non-isolated lacrimal gland involvement in idiopathic orbital inflammation
Purpose To evaluate the clinical data of idiopathic orbital inflammation with isolated and non-isolated lacrimal gland involvement. Methods The medical records of patients who were diagnosed with idiopathic orbital inflammation between January 2016 and June 2022 were evaluated. The patients were divided into 2 groups: isolated and non-isolated lacrimal gland involvement, and were compared in terms of clinical characteristics, response to treatment and recurrence rates. Results Thirty-three eyes of 32 patients (21 female, 11 male) were included in the study. The mean age of the patients was 47.4 ± 14.8 (range, 11–70). The mean follow-up period was 37.4 ± 21.5 (range, 6–76) months. Isolated lacrimal gland involvement was found in 18 eyes (54.5%), myositis and orbital adipose tissue involvement in addition to lacrimal gland involvement in 13 eyes (39.4%), and diffuse orbital inflammation in two eyes (6.1%). While a total of 24 patients (75.0%) were treated with systemic steroids alone, immunosuppressive drugs were used in addition to steroids in eight patients (25.0%). In patients with isolated lacrimal gland involvement, complete recovery with steroid treatment was significantly higher (p = 0.02), while the need for immunosuppressant medication (p = 0.02) and recurrence rates (p = 0.006) were found to be significantly lower. Conclusion To the best of our knowledge, this is the first study to describe and compare the clinical features and treatment outcomes of lacrimal gland biopsy-proven idiopathic orbital inflammation according to the extent of involvement. Knowing whether lacrimal gland involvement is isolated or not may help predict steroid resistance and recurrence risk in patient management.
- Open Access
- 17 June 2025
- Published by Springer Nature in Annals of Hematology
- Vol. 104 (7) , 3829-3836
Secondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study
Patients with mycosis fungoides (MF) are at an increased risk of developing secondary neoplasms. We conducted a comparative analysis between MF patients with and without secondary neoplasms and non-MF patients to assess secondary neoplasm occurrence and identify potential risk factors. We aimed to evaluate the prevalence of secondary neoplasms and investigate associated risk factors in MF patients. Demographic data, treatments, phototherapy details, neoplasm occurrence and detection time, and mortality rates were collected and retrospectively analyzed for 252 MF and 278 control patients. The prevalence of secondary neoplasms was significantly higher in the MF group (13.9%) compared to the control group (3.6%) ( p < 0.001). MF patients with neoplasms had a higher average age and older age at MF diagnosis ( p = 0.003 and 0.016, respectively). Phototherapy type showed no significant association with neoplasm presence. Elevated initial and final beta-2 microglobulin levels were observed in MF patients with neoplasms ( p = 0.002 and 0.005, respectively). MF patients have a higher risk of developing secondary neoplasms compared to controls. Risk increases with older age at MF diagnosis and elevated beta-2 microglobulin levels. Phototherapy was not associated with the development of secondary neoplasms in MF patients. MF patients with secondary neoplasms exhibit higher mortality rates, underscoring the importance of early detection and vigilant monitoring.
- 17 June 2025
- Published by Springer Nature in Annals of Hematology
- Vol. 104 (7) , 3829-3836
Open AccessSecondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study
Patients with mycosis fungoides (MF) are at an increased risk of developing secondary neoplasms. We conducted a comparative analysis between MF patients with and without secondary neoplasms and non-MF patients to assess secondary neoplasm occurrence and identify potential risk factors. We aimed to evaluate the prevalence of secondary neoplasms and investigate associated risk factors in MF patients. Demographic data, treatments, phototherapy details, neoplasm occurrence and detection time, and mortality rates were collected and retrospectively analyzed for 252 MF and 278 control patients. The prevalence of secondary neoplasms was significantly higher in the MF group (13.9%) compared to the control group (3.6%) ( p < 0.001). MF patients with neoplasms had a higher average age and older age at MF diagnosis ( p = 0.003 and 0.016, respectively). Phototherapy type showed no significant association with neoplasm presence. Elevated initial and final beta-2 microglobulin levels were observed in MF patients with neoplasms ( p = 0.002 and 0.005, respectively). MF patients have a higher risk of developing secondary neoplasms compared to controls. Risk increases with older age at MF diagnosis and elevated beta-2 microglobulin levels. Phototherapy was not associated with the development of secondary neoplasms in MF patients. MF patients with secondary neoplasms exhibit higher mortality rates, underscoring the importance of early detection and vigilant monitoring.
- 3 July 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 39 (5) , 543-546
Pleural angiosarcoma presenting with spontaneous hemothorax
Angiosarcomas (ASs) are very rare and constitute 1–2% of soft tissue malignancies. Primary pleural AS (PPAS) is a very rare neoplasm, with only 50 cases reported in the literatüre, and is a tumor with a high tendency for local recurrence and metastasis, with an aggressive course and a generally poor prognosis unless diagnosed early. It originates from the endothelial cells of small blood vessels and therefore can affect many organs. The etiology and definitive method in the treatment is still unclear. Patients usually present with nonspecific symptoms such as cough, dyspnea, chest pain, and hemoptysis. Recurrent exudative or hemorrhagic pleural effusion may develop due to its pleural location. The diagnosis can be made by histopathological and immunohistochemical examinations of excisional biopsy specimens. The effectiveness of chemotherapy and radiotherapy is weak and can be applied for palliative purposes. Surgical approach can be used for diagnostic and palliative purposes. Due to the high degree of malignancy and insidious course of PPAS, patients usually die within months after diagnosis. In these patients, surgical exploration is important for the diagnosis and palliative/definitive treatment of the disease. We present a 61-year-old male patient who presented with dyspnea, chest pain, and massive pleural effusion findings in the left hemithorax and was diagnosed with PPAS as a result of pleural biopsy.
- 3 July 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 39 (5) , 543-546
Pleural angiosarcoma presenting with spontaneous hemothorax
Angiosarcomas (ASs) are very rare and constitute 1–2% of soft tissue malignancies. Primary pleural AS (PPAS) is a very rare neoplasm, with only 50 cases reported in the literatüre, and is a tumor with a high tendency for local recurrence and metastasis, with an aggressive course and a generally poor prognosis unless diagnosed early. It originates from the endothelial cells of small blood vessels and therefore can affect many organs. The etiology and definitive method in the treatment is still unclear. Patients usually present with nonspecific symptoms such as cough, dyspnea, chest pain, and hemoptysis. Recurrent exudative or hemorrhagic pleural effusion may develop due to its pleural location. The diagnosis can be made by histopathological and immunohistochemical examinations of excisional biopsy specimens. The effectiveness of chemotherapy and radiotherapy is weak and can be applied for palliative purposes. Surgical approach can be used for diagnostic and palliative purposes. Due to the high degree of malignancy and insidious course of PPAS, patients usually die within months after diagnosis. In these patients, surgical exploration is important for the diagnosis and palliative/definitive treatment of the disease. We present a 61-year-old male patient who presented with dyspnea, chest pain, and massive pleural effusion findings in the left hemithorax and was diagnosed with PPAS as a result of pleural biopsy.
- Open Access
- 1 January 2016
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 32 (2)
The importance of minor salivary gland biopsy in sjögren syndrome diagnosis and the clinicopathological correlation
Minor salivary gland biopsy is one of the objective tests used in the diagnosis of Sjögren syndrome. The aim of our study was to compare the clinical and laboratory data of primary and secondary Sjögren syndrome cases with a lymphocyte score 3 and 4 in the minor salivary gland biopsy.
- 1 January 2016
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 32 (2)
Open AccessThe importance of minor salivary gland biopsy in sjögren syndrome diagnosis and the clinicopathological correlation
Minor salivary gland biopsy is one of the objective tests used in the diagnosis of Sjögren syndrome. The aim of our study was to compare the clinical and laboratory data of primary and secondary Sjögren syndrome cases with a lymphocyte score 3 and 4 in the minor salivary gland biopsy.
- Open Access
- 6 January 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (23) , 10451-10456
A Retrospective Multicenter Evaluation of Cutaneous Melanomas in Turkey
We defined melanoma distribution in a large series of Turkish patients and evaluated the prognostic parameters of melanomas.A total of 1574 patients' data was retrospectively collected at 18 centers in Turkey. Demographic characteristics were questioned and noted. Prognostic parametres were evaluated based on sentinel lymph node involvement.Mean age was 56.7 (4-99) years. While 844 (53.6%) cases were male, 730 (46.4%) cases were female. One thousand four hundred forty-seven (92%) cases were invasive melanoma and 127 (8%) cases were in-situ melanoma. The most common histopathological form was the superficial spreading melanoma (SSM) which was found in 549 patients (37.9%). It was followed by nodular melanoma in 379 (26.2%), acral lentiginous melanoma (ALM) in 191 (13.2%) and lentigo maligna melanoma in 132 (9.1%), respectively. On univariate analysis, lymphovascular invasion (p<0.001), tumor thickness (p<0.001), histopathological subtype (p<0.001), Clark level (p=0.001), ulceration (p<0.001), ≥6/mm2 mitosis (p=0.005), satellite formation (p=0.001) and gender (p=0.03) were found to be associated with sentinel lymph node positivity. Regression was associated with sentinel lymph node negativity (p=0.017). According to multivariate analysis, lymphovascular invasion and tumor thickness were significant independent predictive factors of SLN positivity. Patient age, tumor localization, precursor lesions, lymphocytic infiltration and neurotropism were not related with sentinel lymph node involvement.In this retrospective analysis, it was found that the prevalence of SSM is at a lower rate while the prevalence of ALM is at a higher rate when compared to western countries. According to Breslow index; most of the melanoma lesions' thickness were greater than 2 mm, corresponding Clark IV. Vascular invasion and tumor thickness are the most important factors for sentinel lymph node involvement.
- 6 January 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (23) , 10451-10456
Open AccessA Retrospective Multicenter Evaluation of Cutaneous Melanomas in Turkey
We defined melanoma distribution in a large series of Turkish patients and evaluated the prognostic parameters of melanomas.A total of 1574 patients' data was retrospectively collected at 18 centers in Turkey. Demographic characteristics were questioned and noted. Prognostic parametres were evaluated based on sentinel lymph node involvement.Mean age was 56.7 (4-99) years. While 844 (53.6%) cases were male, 730 (46.4%) cases were female. One thousand four hundred forty-seven (92%) cases were invasive melanoma and 127 (8%) cases were in-situ melanoma. The most common histopathological form was the superficial spreading melanoma (SSM) which was found in 549 patients (37.9%). It was followed by nodular melanoma in 379 (26.2%), acral lentiginous melanoma (ALM) in 191 (13.2%) and lentigo maligna melanoma in 132 (9.1%), respectively. On univariate analysis, lymphovascular invasion (p<0.001), tumor thickness (p<0.001), histopathological subtype (p<0.001), Clark level (p=0.001), ulceration (p<0.001), ≥6/mm2 mitosis (p=0.005), satellite formation (p=0.001) and gender (p=0.03) were found to be associated with sentinel lymph node positivity. Regression was associated with sentinel lymph node negativity (p=0.017). According to multivariate analysis, lymphovascular invasion and tumor thickness were significant independent predictive factors of SLN positivity. Patient age, tumor localization, precursor lesions, lymphocytic infiltration and neurotropism were not related with sentinel lymph node involvement.In this retrospective analysis, it was found that the prevalence of SSM is at a lower rate while the prevalence of ALM is at a higher rate when compared to western countries. According to Breslow index; most of the melanoma lesions' thickness were greater than 2 mm, corresponding Clark IV. Vascular invasion and tumor thickness are the most important factors for sentinel lymph node involvement.
- Open Access
- 1 January 2015
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 31 (2)
Atypia and differential diagnosis in cellular blue nevi: clinicopathological study of 21 cases
Cellular blue nevus differs from the classic blue nevus with characteristics such as large size, cellularity, intense pigmentation, and growing pattern with subcutaneous infiltration. It is a dermal melanocytic tumor that can be confused with melanoma due to the atypia it may contain.
- 1 January 2015
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 31 (2)
Open AccessAtypia and differential diagnosis in cellular blue nevi: clinicopathological study of 21 cases
Cellular blue nevus differs from the classic blue nevus with characteristics such as large size, cellularity, intense pigmentation, and growing pattern with subcutaneous infiltration. It is a dermal melanocytic tumor that can be confused with melanoma due to the atypia it may contain.
- Open Access
- 1 January 2014
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 30 (1) , 55-65
Prognostic significance of bcl-2, c-myc, survivin and tumor grade in synovial sarcoma
- 1 January 2014
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 30 (1) , 55-65
Open AccessPrognostic significance of bcl-2, c-myc, survivin and tumor grade in synovial sarcoma
- Open Access
- 1 January 2013
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 29 (2) , 108
Follicular mucinosis and follicular mycosis fungoides: clinicopathological evaluation of seven cases
Follicular mucinosis is a disease characterized by follicular degeneration and mucin accumulation. It can be seen in mycosis fungoides, although idiopathic or forms associated with other diseases are also known. Follicular mycosis fungoides is a type of mycosis fungoides with different clinicopathological and prognostic features.
- 1 January 2013
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 29 (2) , 108
Open AccessFollicular mucinosis and follicular mycosis fungoides: clinicopathological evaluation of seven cases
Follicular mucinosis is a disease characterized by follicular degeneration and mucin accumulation. It can be seen in mycosis fungoides, although idiopathic or forms associated with other diseases are also known. Follicular mycosis fungoides is a type of mycosis fungoides with different clinicopathological and prognostic features.